LTRN logo

Lantern Pharma Inc. Common Stock


LTRN: Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence (A.I), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves four drug candidates and an Antibody Drug Conjugate (ADC) program directed towards eight therapeutic targets.


Show LTRN Financials

Consumer Interest
SEC Filings

Recent trades of LTRN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by LTRN's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Increasing cancer patient survival time by administration of dithio-containing compounds Oct. 18, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of LTRN in WallStreetBets Daily Discussion


Recent insights relating to LTRN

CNBC Recommendations

Recent picks made for LTRN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LTRN

Corporate Flights

Flights by private jets registered to LTRN